PCI Pharma Services, a leading global CDMO focused on biopharma's most complex therapies, has invested over $365 million in EU and US facilities for clinical and commercial supply of advanced drug delivery and drug-device combination products. The company also announced a $100 million investment in New Hampshire to expand its sterile liquid filling and lyophilization capabilities. PCI's total worth is not explicitly stated but can be inferred to be substantial based on its significant investments and global presence.
5 answers
Claudio
Sat Nov 09 2024
The financial details of the agreement have not been made public.
Martina
Fri Nov 08 2024
According to information obtained by Fortune, the transaction values PCI at slightly above $1 billion.
CryptoConqueror
Fri Nov 08 2024
This valuation includes the company's debt.
Federica
Fri Nov 08 2024
Frazier, one of the parties involved, will use a portion of the proceeds from the deal.
Alessandra
Fri Nov 08 2024
Frazier's intention is to retain a minority equity position in PCI.